Horizon Therapeutics PLC HZNP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/26/22 EDT
61.79UNCH (UNCH)
Volume
530,642
Close
61.79quote price arrow down-1.18 (-1.87%)
Volume
3,399,253
52 week range
57.84 - 120.53
Loading...
  • Open63.01
  • Day High64.19
  • Day Low61.44
  • Prev Close61.79
  • 52 Week High120.53
  • 52 Week High Date11/01/21
  • 52 Week Low57.84
  • 52 Week Low Date09/01/22

Key Stats

  • Market Cap14.235B
  • Shares Out230.38M
  • 10 Day Average Volume2.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-42.66

KEY STATS

  • Open63.01
  • Day High64.19
  • Day Low61.44
  • Prev Close61.79
  • 52 Week High120.53
  • 52 Week High Date11/01/21
  • 52 Week Low57.84
  • 52 Week Low Date09/01/22
  • Market Cap14.235B
  • Shares Out230.38M
  • 10 Day Average Volume2.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-42.66

RATIOS/PROFITABILITY

  • EPS (TTM)3.24
  • P/E (TTM)19.09
  • Fwd P/E (NTM)13.39
  • EBITDA (TTM)1.368B
  • ROE (TTM)16.96%
  • Revenue (TTM)3.813B
  • Gross Margin (TTM)75.39%
  • Net Margin (TTM)20.06%
  • Debt To Equity (MRQ)51.91%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Horizon Therapeutics PLC

Profile

MORE
Horizon Therapeutics plc is a global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The Company's portfolio is composed of approximately 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. The Company operates through two segments: orphan segment and the inflammation segment. The...
Timothy Walbert
Chairman of the Board, President, Chief Executive Officer
Aaron Cox
Chief Financial Officer, Executive Vice President
Sean Clayton
Executive Vice President, General Counsel
Andy Pasternak
Executive Vice President, Chief Strategy Officer
Michael DesJardin
Executive Vice President - Technical Operations and Corporate Quality
Address
Connaught House
1St Floor, 1 Burlington Road
Dublin
D04 C5Y6
Ireland

Top Peers

SYMBOLLASTCHG%CHG
CTLT
Catalent Inc
74.73-1.34-1.76%
BMRN
Biomarin Pharmaceutical Inc
82.16-2.68-3.16%
RPRX
Royalty Pharma PLC
39.88-0.45-1.12%
RDY
Dr Reddy's Laboratories Ltd
49.90-0.75-1.48%
UTHR
United Therapeutics Corp
203.30-4.32-2.08%